Human Antibody Responses to the Polyclonal Dryvax Vaccine for Smallpox Prevention Can Be Distinguished from Responses to the Monoclonal Replacement Vaccine ACAM2000

Dryvax (Wyeth Laboratories, Inc., Marietta, PA) is representative of the vaccinia virus preparations that were previously used for preventing smallpox. While Dryvax was highly effective, the national supply stocks were depleted, and there were manufacturing concerns regarding sterility and the clona...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Pugh, Christine, Keasey, Sarah, Korman, Lawrence, Pittman, Phillip R., Ulrich, Robert G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2014
Ämnen:
Vaccines
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4054243/
https://ncbi.nlm.nih.gov/pubmed/24759651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00035-14
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk